More than half a million bottles of blood pressure medication are being recalled over a cancer-causing chemical connected to ...

More than 500,000 bottles of blood pressure medication have been recalled for having high levels of a cancer-causing chemical ...

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes ...

Walmart is joining Costco, Sam’s Club, and CVS in offering cheaper prices for customers paying out of pocket for Zepbound, ...

China's Innovent Biologics saidon Monday its GLP-1 injection led to more weight loss and better control of blood sugar in ...

Pharmaceutical company issues voluntary recall for blood pressure medication over cancer-causing chemical being found in the ...

Semaglutide, the diabetes drug at the center of a global boom in weight-loss treatments, has entered the Moroccan market through a partnership between Danish pharmaceutical company Novo Nordisk and ...

Cagrilintide and semaglutide have each been shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema) for weight ...

iControlled for family-wise type 1 error rate. iiPercentage of participants achieving body weight reductions of ≥20% with orforglipron 6 mg was not controlled for ...

Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia ...